Acute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsPalliative Care and End-of-Life IssuesAcute Lymphoblastic Leukemia researchChronic Lymphocytic Leukemia Research
Publications
194
Citations
6,539
Est. group size
—
Recurring co-author estimate
Active years
48
Publishing since 1979
Publication cadence
Publications per year over the last 10 years — averaging 5.4/year recently
Recent publications
- NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026
Journal of the National Comprehensive Cancer Network · 2026
- FLT3-SYK inhibitor and Ixazomib combination impact HOXA and oxidative stress control by β-catenin, SQSTM1 and NRF2 in AML
npj Precision Oncology · 2026
- Elevated levels of TNF and its targets characterize better-risk older acute myeloid leukemia patients
Leukemia · 2026
- Sparse whole genome sequencing and machine learning of AML genomes reveals novel, clinically relevant genetics.
Blood · 2025
- Major adverse cardiovascular events (MACE) in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: A target trial emulation study
Blood · 2025
- Inferior survival in black AML patients treated with intensive chemotherapy in ECOG-ACRIN clinical trials is independent of cytogenetic profiles
Blood · 2025
- Comparative risk of major adverse cardiovascular events in polycythemia vera patients treated with ruxolitinib, hydroxyurea, or interferon: A real-world, propensity-matched cohort study
Blood · 2025
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024
Journal of the National Comprehensive Cancer Network · 2024
- Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials
Bone Marrow Transplantation · 2024
- Correction: Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials
Bone Marrow Transplantation · 2024
- The Goal Inventory: An Innovative Digital Resource to Help Patients Identify and Evaluate Their Goals
Journal of Pain and Symptom Management · 2024
- Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG‐ACRIN analysis
Cancer · 2023
- MDS-641 Randomized Phase 1-2 Study to Assess Safety and Efficacy of Low-Dose (LD) Oral Decitabine/Cedazuridine (ASTX727) in Lower-Risk Myelodysplastic Syndromes (LR-MDS) Patients: Interim Safety Analysis
Clinical Lymphoma Myeloma & Leukemia · 2023
- Correction: Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999
Blood Cancer Journal · 2023
- Supplementary Methods, Table 1, Figure Legend 1 from A Noncanonical Flt3ITD/NF-κB Signaling Pathway Represses <i>DAPK1</i> in Acute Myeloid Leukemia
2023
Publishes in
- Blood×13
- Journal of Clinical Oncology×3
- Leukemia Research×3
- American Journal of Hospice and Palliative Medicine®×3
- Author eBooks×3
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 9, 2026.
Claim or correct this profile